About Dr Munro
Malcolm G. Munro MD, FRCSC, FACOG, FRCOG (Hon)
Dr. Munro is a Clinical Professor in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA, in Los Angeles, California . Dr. Munro’s clinical and research interests are oriented to disorders of the uterus, adnexae and surrounding structures including diagnosis, medical management and, when needed, minimally invasive approaches be they hysteroscopic, laparoscopic, vaginal or image guided. Dr Munro has developed systems and techniques for the performance of virtually all hysteroscopic and other intrauterine procedures in an office environment, solely with local anesthesia, and approach that adds safety, frees up operating rooms, and reduces costs for both patients and the health care system (Link). He has demonstrated skills in surgical education and training and was  the Principal Investigator for the EMIG Manual Skills Construct Validation Trial,a joint effort of the AAGL, CREOG and the American College of Obsetricians and Gynecologists for gynecologic endoscopy training and high stakes testing. The results of this trial and the associated development of educational content and cognitive testing have created a process that is now one of the requirements for certification by the American Board of Obstetrics and Gynecology. He is was a Co-founder, previous Chair, and a continuing member of the FIGO Committee on Menstrual Disorders and Related Health Impacts that has been responsible for the development and publication of the two FIGO AUB Systems for Symptoms and Classification of causes, the FIGO Leiomyoma Classification System, and the FIGO Ovulatory Disorders Classification System now used worldwide by investigators, clinicians, and educators. Dr Munro was a founding co-Chair of the SEUD Abnormal Uterine Bleeding Task Force and is Head of the Menstruation and Abnormal Uterine Bleeding Section of F1000Prime. He has published more than 140 papers, 45 chapters, and five books including Abnormal Uterine Bleeding, released by Cambridge University Press and, recently, with Professor Victor Gomel, Reproductive and Reconstructive Gynecologic Surgery. Dr Munro is also on the Editorial Boards of the Journal of Minimally Invasive Gynecology and Human Reproduction as well as a reviewer for numerous other peer-reviewed specialty journals. He has served the American Association of Gynecologic Laparoscopists (AAGL) as a member of the Board of Trustees (2000-2002) and was the inaugural chair of the AAGL Practice Committee, charged with the development of evidence based practice guidelines related to minimally invasive approaches to gynecology. 

As a consultant to the pharmaceutical and device industry, Dr. Munro advises on device development, product research design, new business development, marketing programs, economic modeling, and legal and regulatory issues. These services have culminated in device development and modification, product submissions, and presentations to the relevant FDA panel. Included in Dr. Munro’s current or past corporate clients are a spectrum of companies ranging from early stage to multinational corporate entities, such as Abbvie Inc, Abbott, Aegea Inc, American Regent, Andronic Devices, Boston Scientific, Caldera Medical, Channel Medical, ConMed Inc, CooperSurgical Inc,  Covidien, Cross Bay Medical, Daiichi Sankyo Pharmaceuticals,  Ethicon Women’s Health and Urology, Ethicon Endosurgery,  Graphic Surgery LLC, Gynesonics Inc, Hologic Inc, Idolman US and Canada, Karl Storz Endoscopy Americas, Myovant Inc, Okon Medical, Pharmacosmos,  Rejoni Inc, Shield Therapeutics, Veldana and Vifor Pharma. Dr Munro holds, or coholds eight device patents. 
Selected Publications
Munro MG, Balen A, Cho S. et al. The FIGO Ovulatory Disorders Classification System. Hum Reprod, 2022;37:2446-2464.

Munro MG, Gomel V. Reconstructive and Reproductive Surgery in Gynecology. 2019 CRC Press. Two volume electronic and hard copy. Includes 130 videos. Volumes 1 & 2
Munro MG, Critchley HOD, Fraser IS. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018 Dec;143(3):393-408
Munro MG, Brown AN, Saadat S et al. Essentials in Minimally Invasive Gynecology Manual Skills Pilot Validation Trial. J Minim Invasive Gynecol. 2020 Feb;27(2):518-534

Munro MG, Advincula AP, Banks EH, et al. Essentials in Minimally Invasive Gynecology Manual Skills Construct Validation Trial. Obstetrics Gynecology 2020; 136:83-96.
Munro MG. Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity. Fertil Steril. 2019 Apr;111(4):629-640

Keyhan S, Munro MG. Office diagnostic and operative hysteroscopy using local anesthesia only: an analysis of patient reported pain and other procedural outcomes. J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):791-8

Munro MG, for the SCPMG AUB Working Group. Acute uterine bleeding unrelated to pregnancy: a Southern California Permanente Medical Group practice guideline. Perm J. 2013 Summer;17(3):43-56

Munro MG, Dickersin K, Clark MA, et al. The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Menopause. 2011 Apr;18(4):445-52

Munro MG, Brill AI, Ryan T, Ciarrocca S. Electrosurgery-induced generation of gases: comparison of in vitro rates of production using bipolar and monopolar electrodes. J Am Assoc Gynecol Laparosc. 2003 May;10(2):252-9

Munro MG. Mechanisms of thermal injury to the lower genital tract with radiofrequency resectoscopic surgery. J Minim Invasive Gynecol. 2006 Jan-Feb;13(1):36-42
Share by: